Study Title: A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer: Big Ten Cancer Research Consortium. BTCRC-LUN17-127
 

• Open to Accrual at:
  • University of Illinois Cancer Center
  • Masonic Cancer Center, University of Minnesota
  • Rutgers Cancer Institute of New Jersey
  • Moffitt Cancer Center
• Closed to Accrual at: 
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center
• Learn more:
  • clinicaltrials.gov: NCT03575793
  • Big Ten CRC News Release
• Publications and Presentations:
  • Poster Session: 2021 ASCO Annual Meeting

Study Contact: studies@hoosiercancer.org; (317) 921-2050.